Prof Simon Harrison is the Director of the Centre of Excellence in Cellular Immunotherapy and a leading Haematologist in the Myeloma team at the Peter MacCallum Cancer Centre.
He has been appointed as incoming Chair of Australia’s Myeloma Scientific & Advisory Group (MSAG).
He is also Director of Clinical Apheresis at Peter Mac, and a clinician scientist in the Sir Peter MacCallum department of Oncology in Melbourne University.
His clinical research is focused in the field of multiple myeloma examining novel therapies including novel drug combinations, early phase clinical trial design and the incorporation of novel biomarkers into clinical protocols and cellular therapy.
Prof Harrison work focuses on the immunopathology of multiple myeloma, the impact of novel drug combinations and immune therapies. He is also collaborating on the development of POL1 inhibitors in combination with other novel drugs to target ribosome biogenesis.